Chinese Journal of Tissue Engineering Research ›› 2015, Vol. 19 ›› Issue (27): 4288-4292.doi: 10.3969/j.issn.2095-4344.2015.27.005

Previous Articles     Next Articles

Cardiomyocyte apoptosis in rats with myocardial ischemia/reperfusion injury after Exendin-4 pretreatment 

Li Wen-kai1, Shang Bin1, Lian Xiao-peng1, Ma Jie2   

  1. 1Shanxi Medical University, Taiyuan 030001, Shanxi Province, China; Department of Cardiothoracic Surgery, the Second Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi Province, China
  • Online:2015-06-30 Published:2015-06-30
  • Contact: Ma Jie, M.D., Professor, Chief physician, Doctoral supervisor, Department of Cardiothoracic Surgery, the Second Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi Province, China
  • About author:Li Wen-kai, Studying for master’s degree, Shanxi Medical University, Taiyuan 030001, Shanxi Province, China

Abstract:

BACKGROUND: Exendin can regulate blood glucose, blood lipid and blood pressure, exert anti-inflammation and anti-oxidative stress effects, improve myocardial infarction and heart failure, and protect heart vessels. However, the effect on the apoptosis of cardiac muscle cells after ischemia/reperfusion injury remains unclear.
OBJECTIVE: To observe the effects of Exendin-4 pretreatment on the cardiomyocyte apoptosis and the expression of Bcl-2 and Bax in rats with myocardial ischemia/reperfusion injury.
METHODS: The myocardial ischemia/reperfusion injury model was established in rats and then received Exendin-4 pretreatment. Ischemia/reperfusion group and sham operation group were set.
RESULTS AND CONCLUSION: Immunohistochemical staining, TUNEL and reverse transcriptase-polymerase chain reaction results showed that Bcl-2 protein and mRNA expression levels in the Exendin-4 group were significantly increased (P < 0.05), while Bax protein and mRNA expression levels were significantly decreased compared with ischemia/reperfusion group (P < 0.05). In addition, apoptosis index was more significantly decreased in the Exendin-4 group than in the ischemia/reperfusion group (P < 0.05). Exendin-4 can protect rat heart muscle against ischemia/reperfusion injury and effectively inhibit the apoptosis of cardiomyocytes, and the underlying mechanism is mediated by up-regulating Bcl-2 expression and down-regulating Bax expression.

中国组织工程研究杂志出版内容重点:肾移植肝移植移植;心脏移植;组织移植;皮肤移植;皮瓣移植;血管移植;器官移植组织工程

Key words: Tissue Engineering, Myocardial Ischemia, Apoptosis, Genes 

CLC Number: